Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12588]

ECC 2013: Biological therapy with cediranib improves survival in women with recurrent ovarian cancer

ECC 2013: Biological therapy with cediranib improves survival in women with recurrent ovarian cancer

$ECC 2013: Hyperfractionated radiotherapy improves survival in head and neck cancer patients$

ECC 2013: Hyperfractionated radiotherapy improves survival in head and neck cancer patients

ECC 2013: Treating chest lymph nodes in patients with early breast cancer improves survival without increasing side effects

ECC 2013: Treating chest lymph nodes in patients with early breast cancer improves survival without increasing...

ECC 2013: Longest follow-up of largest number of melanoma patients treated with ipilimumab shows some survive up to ten years

ECC 2013: Longest follow-up of largest number of melanoma patients treated with ipilimumab shows some survive up...

ECC 2013: Anti-cancer drug T-DM1 benefits women with advanced breast cancer who have failed several previous treatments: results from TH3RESA trial

ECC 2013: Anti-cancer drug T-DM1 benefits women with advanced breast cancer who have failed several previous...

ECC 2013: New research shows how aspirin may act on blood platelets to improve survival in colon cancer patients

ECC 2013: New research shows how aspirin may act on blood platelets to improve survival in colon cancer patients

ECC 2013: New trial combining anti-cancer drug and radiotherapy may result in a new treatment for the most aggressive brain tumour

ECC 2013: New trial combining anti-cancer drug and radiotherapy may result in a new treatment for the most...

ECC 2013: Organised screening for prostate cancer using the prostate-specific antigen test, does more harm than good

ECC 2013: Organised screening for prostate cancer using the prostate-specific antigen test, does more harm than...

ECC 2013: Survival after cancer diagnosis in Europe strongly associated with government health care expenditure

ECC 2013: Survival after cancer diagnosis in Europe strongly associated with government health care expenditure

ECC 2013: Young patients with metastatic colorectal cancer are at high risk of disease progression and death

ECC 2013: Young patients with metastatic colorectal cancer are at high risk of disease progression and death

More from ecancer